tiprankstipranks
Trending News
More News >
Adient (ADNT)
NYSE:ADNT

Adient (ADNT) AI Stock Analysis

Compare
422 Followers

Top Page

ADNT

Adient

(NYSE:ADNT)

Select Model
Select Model
Select Model
Neutral 57 (OpenAI - 5.2)
Rating:57Neutral
Price Target:
$24.00
▲(15.38% Upside)
The score is held back primarily by weak profitability and high leverage despite modest revenue growth and some free-cash-flow generation. Technical momentum is positive but looks overextended, while valuation is constrained by negative earnings. Earnings-call guidance and cost/financing initiatives provide moderate support but do not fully offset margin and restructuring headwinds.
Positive Factors
Strong Free Cash Flow
Exceeding free cash flow guidance indicates robust cash generation, providing financial flexibility for investments and debt reduction.
New Business Wins in China
Securing significant new contracts in China strengthens market position and supports revenue growth in a key automotive market.
Operational Efficiency
Improved operational efficiency enhances profitability and competitiveness, supporting long-term financial health and market position.
Negative Factors
High Leverage
High leverage increases financial risk and limits flexibility, potentially impacting the company's ability to invest and grow sustainably.
Negative Profitability
Negative profitability undermines financial stability and can hinder reinvestment in growth and innovation, affecting long-term viability.
Volume and Mix Headwinds
Volume and mix headwinds can reduce revenue and margins, challenging the company's ability to maintain growth and profitability.

Adient (ADNT) vs. SPDR S&P 500 ETF (SPY)

Adient Business Overview & Revenue Model

Company DescriptionAdient plc designs, develops, manufactures, and markets a range of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's seating solutions include frames, mechanisms, foams, head restraints, armrests, and trim covers. It serves automotive original equipment manufacturers in the Americas, including North America and South America; Europe, Middle East, and Africa; and Asia Pacific. The company was incorporated in 2016 and is based in Dublin, Ireland.
How the Company Makes MoneyAdient generates revenue primarily through the sale of automotive seating systems and components to original equipment manufacturers (OEMs) and suppliers in the automotive industry. The company operates on a business model that includes long-term contracts with automotive manufacturers, which ensures a steady stream of income. Key revenue streams include the production and supply of seat structures, foam, and trim, as well as specialized seating solutions that incorporate advanced technologies such as adjustable seating and integrated safety features. Additionally, partnerships with leading automotive brands and participation in global automotive programs contribute significantly to its earnings. Factors such as market demand for vehicles, trends in vehicle design and technology, and the overall health of the automotive industry play crucial roles in influencing Adient's financial performance.

Adient Earnings Call Summary

Earnings Call Date:Nov 05, 2025
(Q4-2025)
|
% Change Since: |
Next Earnings Date:Feb 04, 2026
Earnings Call Sentiment Neutral
Adient demonstrated resilience and strong operational performance despite facing significant challenges such as volume and mix headwinds, high restructuring costs, and tariff impacts. The company made significant new business wins and optimized its capital structure, but faced substantial decremental margin challenges due to external factors.
Q4-2025 Updates
Positive Updates
Strong Free Cash Flow
Adient delivered a free cash flow of $134 million in Q4 and $204 million for the full year, surpassing the high end of their guidance range of $170 million.
Successful New Business Wins
Adient won $1.2 billion of new business in China, with nearly 70% of those wins with domestic China OEMs. They also secured replacement and conquest business on major platforms like the Ford F-150.
Operational Performance and Efficiency
Operational performance delivered over $100 million of business performance this year, excluding the net impact of tariffs. Adient is also investing in AI and automation, expecting $40 million in savings.
Amendment and Extension of ABL Revolver
Adient extended the maturity of their ABL revolver from 2027 to 2030 and reduced the revolver by $250 million, optimizing cash needs and reducing interest expense.
Negative Updates
Volume and Mix Headwinds
The company faced $50 million of unfavorable volume and mix headwinds due to lower volumes in Europe and other customer mix headwinds in Asia.
Decremental Margin Challenges
Adient faced significant decremental margins due to F-150 and Nexperia downtime, with high costs due to short notice and sub-pay impacts.
Elevated Restructuring Costs
Restructuring costs remained high at $120 million for fiscal year 2026, with expectations to normalize to $50 million in the future.
Impact of Tariffs
Net tariff expense was $17 million, impacting overall business performance despite efforts to mitigate these costs.
Company Guidance
During Adient's fourth quarter and full year 2025 earnings call, the company provided guidance for fiscal year 2026, outlining several key metrics and strategic initiatives. Adient expects to generate approximately $14.8 billion in sales and $925 million in adjusted EBITDA, with an adjusted EBITDA margin of about 6.3% if volumes remain constant. They project $90 million in free cash flow based on current volume assumptions, though this could increase to $170 million if volumes remain steady. The company reported a full-year adjusted EBITDA of $881 million on $14.5 billion in sales for 2025, with an adjusted EBITDA margin of 6.1%. Free cash flow for the year reached $204 million, exceeding their guidance range, allowing for $125 million in share buybacks. Adient highlighted accomplishments such as securing $1.2 billion in new business in China and making strides in automation and artificial intelligence. The company aims for substantial growth over market in China and mid-single-digit growth over market in North America by 2027, driven by strategic investments and partnerships.

Adient Financial Statement Overview

Summary
Mixed fundamentals: revenue growth is positive (8.74% TTM) and gross margin improved slightly, but profitability has deteriorated (net margin -1.35%, negative ROE -10.47%) and leverage is elevated (debt-to-equity 1.34). Cash flow is a relative support, though free cash flow growth is down (-21.84% TTM).
Income Statement
55
Neutral
Adient's income statement shows mixed performance. The TTM gross profit margin is 6.66%, slightly above the previous year's 6.32%, indicating some improvement in cost management. However, the net profit margin has turned negative at -1.35%, reflecting a loss in profitability. Revenue growth is positive at 8.74% TTM, but this follows a decline in the previous year. The EBIT and EBITDA margins have decreased, suggesting challenges in operational efficiency.
Balance Sheet
50
Neutral
The balance sheet reveals a high debt-to-equity ratio of 1.34 TTM, indicating significant leverage, which poses a risk. Return on equity is negative at -10.47%, reflecting poor returns for shareholders. The equity ratio is not explicitly calculated, but the high leverage suggests a lower proportion of equity in the capital structure.
Cash Flow
60
Neutral
Cash flow analysis shows a decline in free cash flow growth by -21.84% TTM, indicating potential liquidity issues. However, the operating cash flow to net income ratio is 0.14, suggesting some ability to cover net losses with operating cash. The free cash flow to net income ratio is 0.52, indicating that despite losses, the company is generating some free cash flow.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue14.54B14.69B15.39B14.12B13.68B12.67B
Gross Profit961.00M928.00M1.03B807.00M826.00M592.00M
EBITDA384.00M656.00M828.00M603.00M2.02B119.00M
Net Income-281.00M18.00M205.00M-120.00M1.11B-486.00M
Balance Sheet
Total Assets8.95B9.35B9.42B9.16B10.78B10.26B
Cash, Cash Equivalents and Short-Term Investments958.00M945.00M1.11B947.00M1.52B1.69B
Total Debt2.40B2.40B2.54B2.58B3.70B4.31B
Total Liabilities6.80B6.82B6.82B6.74B7.82B8.68B
Stockholders Equity1.77B2.13B2.23B2.07B2.38B1.21B
Cash Flow
Free Cash Flow205.00M277.00M415.00M47.00M0.00-80.00M
Operating Cash Flow450.00M543.00M667.00M274.00M260.00M246.00M
Investing Cash Flow-186.00M-253.00M-229.00M484.00M347.00M166.00M
Financing Cash Flow-268.00M-502.00M-271.00M-1.27B-770.00M393.00M

Adient Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price20.80
Price Trends
50DMA
19.93
Positive
100DMA
21.60
Negative
200DMA
20.34
Positive
Market Momentum
MACD
0.41
Positive
RSI
48.81
Neutral
STOCH
15.39
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ADNT, the sentiment is Neutral. The current price of 20.8 is below the 20-day moving average (MA) of 21.18, above the 50-day MA of 19.93, and above the 200-day MA of 20.34, indicating a neutral trend. The MACD of 0.41 indicates Positive momentum. The RSI at 48.81 is Neutral, neither overbought nor oversold. The STOCH value of 15.39 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for ADNT.

Adient Risk Analysis

Adient disclosed 37 risk factors in its most recent earnings report. Adient reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Adient Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
$6.07B14.338.96%2.63%-1.90%-13.86%
73
Outperform
$2.48B8.1623.16%0.57%-4.03%-39.51%
72
Outperform
$9.05B13.3140.38%1.07%-4.21%-0.45%
65
Neutral
$10.14B75.972.24%1.24%0.08%-83.69%
61
Neutral
$18.38B12.79-2.54%3.03%1.52%-15.83%
57
Neutral
$1.65B-6.23-14.41%-1.04%-1510.41%
53
Neutral
$3.38B65.41-4.82%1.70%-18.23%
* Consumer Cyclical Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ADNT
Adient
20.80
4.40
26.83%
ALSN
Allison Transmission Holdings
108.70
-2.96
-2.65%
BWA
BorgWarner
47.41
16.71
54.43%
DAN
Dana Incorporated
28.90
13.54
88.15%
LEA
Lear
117.09
28.90
32.77%
VC
Visteon
90.86
10.03
12.40%

Adient Corporate Events

Business Operations and StrategyPrivate Placements and Financing
Adient amends term loan agreement, lowering interest margin
Positive
Jan 16, 2026

On January 15, 2026, Adient and certain subsidiaries amended their existing term loan credit agreement, keeping total outstanding borrowings at $624 million while securing a reduction in the interest rate margin to 2.00% for Term SOFR loans and 1.00% for base rate loans. The obligations under the credit agreement remain secured and guaranteed by Adient plc and key wholly owned restricted subsidiaries, a move that lowers financing costs and supports the company’s capital structure without increasing its debt load, which may enhance financial flexibility for operations and stakeholders.

The most recent analyst rating on (ADNT) stock is a Hold with a $22.00 price target. To see the full list of analyst forecasts on Adient stock, see the ADNT Stock Forecast page.

Private Placements and Financing
Adient Amends Revolving Credit Agreement with JPMorgan
Neutral
Oct 17, 2025

On October 17, 2025, Adient US LLC and Adient plc, along with other loan parties, amended their existing revolving credit agreement with JPMorgan Chase Bank. The amendment extends the maturity date by five years and reduces the aggregate commitments to $1 billion, maintaining secured guarantees by the company and its subsidiaries.

The most recent analyst rating on (ADNT) stock is a Sell with a $20.00 price target. To see the full list of analyst forecasts on Adient stock, see the ADNT Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 17, 2026